Antioxidant and Anti-Inflammatory Properties of Melatonin in Patients with Type 2 Diabetes Mellitus with Periodontal Disease Under Non-Surgical Periodontal Therapy: A Double-Blind, Placebo-Controlled Trial
Ahmad Zare Javid,1,2 Seyed Ahmad Hosseini,1,2 Hassan Gholinezhad,2 Leila Moradi,3 Mohammad Hosein Haghighi-zadeh,4 Hadi Bazyar1,5 1Nutrition and Metabolic Diseases Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran; 2Department of Nutrition, School of Allied Medical Scien...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2020-03-01
|
Series: | Diabetes, Metabolic Syndrome and Obesity |
Subjects: | |
Online Access: | https://www.dovepress.com/antioxidant-and-anti-inflammatory-properties-of-melatonin-in-patients--peer-reviewed-article-DMSO |
_version_ | 1797935568548528128 |
---|---|
author | Zare Javid A Hosseini SA Gholinezhad H Moradi L Haghighi-zadeh MH Bazyar H |
author_facet | Zare Javid A Hosseini SA Gholinezhad H Moradi L Haghighi-zadeh MH Bazyar H |
author_sort | Zare Javid A |
collection | DOAJ |
description | Ahmad Zare Javid,1,2 Seyed Ahmad Hosseini,1,2 Hassan Gholinezhad,2 Leila Moradi,3 Mohammad Hosein Haghighi-zadeh,4 Hadi Bazyar1,5 1Nutrition and Metabolic Diseases Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran; 2Department of Nutrition, School of Allied Medical Sciences, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran; 3Health Research Institute, Diabetes Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran; 4Department of Biostatistics, School of Public Health, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran; 5Student Research Committee, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, IranCorrespondence: Hadi BazyarNutrition and Metabolic Diseases Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, IranTel +98 9136659629Email hadibazyar2015@gmail.comBackground and Aim: The imbalance between pro-oxidant and antioxidant systems often leads to further oxidative damage in the pathogenesis of both diabetes and periodontal disease. This study aimed to investigate the antioxidant and anti-inflammatory properties of melatonin in type 2 diabetes mellitus (T2DM) patients with periodontal disease (PD) under non-surgical periodontal therapy (NSPT).Materials and Methods: In this double-blind clinical trial study, 50 T2DM patients with PD were randomly allocated to intervention and control groups and received 250 mg/day (2 tablets) either melatonin or placebo 1 h before bedtime for 8 weeks. The NSPT was performed for all patients in both groups at the beginning of the study. The serum levels of interleukin-1b (IL-1b), malondialdehyde (MDA), total antioxidant capacity (TAC), superoxide dismutase (SOD), catalase (CAT), and glutathione peroxidase (GPx) were measured pre- and post-intervention.Results: Supplementation with melatonin in adjunct to NSPT significantly increased the serum levels of TAC, SOD, CAT, and GPx in the intervention group (P = 0.02, 0.008, 0.004 and 0.004, respectively). The mean changes of SOD, CAT, and GPx were significantly (P = 0.02, 0.04 and 0.04, respectively) greater in the intervention group compared with the control group. Also, after adjusting for confounding factors, the results did not change in terms of significance (P < 0.05). After the intervention, serum levels of MDA and IL-1b were significantly reduced in the intervention group (P < 0.001 and P = 0.008, respectively). The intervention group exhibited lower mean changes of MDA compared with the control group, and these changes were statistically significant (P = 0.008). In addition, after adjusting for confounding factors, the results did not change in terms of significance.Conclusion: The adjunctive effects of melatonin and NSPT may improve inflammatory and antioxidant parameters in T2DM patients with PD.Keywords: type 2 diabetes mellitus, periodontal disease, melatonin, inflammatory markers, antioxidant enzymes |
first_indexed | 2024-04-10T18:16:15Z |
format | Article |
id | doaj.art-c949613223b141b0a66ac7cdc1d7f7b7 |
institution | Directory Open Access Journal |
issn | 1178-7007 |
language | English |
last_indexed | 2024-04-10T18:16:15Z |
publishDate | 2020-03-01 |
publisher | Dove Medical Press |
record_format | Article |
series | Diabetes, Metabolic Syndrome and Obesity |
spelling | doaj.art-c949613223b141b0a66ac7cdc1d7f7b72023-02-02T08:42:26ZengDove Medical PressDiabetes, Metabolic Syndrome and Obesity1178-70072020-03-01Volume 1375376152561Antioxidant and Anti-Inflammatory Properties of Melatonin in Patients with Type 2 Diabetes Mellitus with Periodontal Disease Under Non-Surgical Periodontal Therapy: A Double-Blind, Placebo-Controlled TrialZare Javid AHosseini SAGholinezhad HMoradi LHaghighi-zadeh MHBazyar HAhmad Zare Javid,1,2 Seyed Ahmad Hosseini,1,2 Hassan Gholinezhad,2 Leila Moradi,3 Mohammad Hosein Haghighi-zadeh,4 Hadi Bazyar1,5 1Nutrition and Metabolic Diseases Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran; 2Department of Nutrition, School of Allied Medical Sciences, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran; 3Health Research Institute, Diabetes Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran; 4Department of Biostatistics, School of Public Health, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran; 5Student Research Committee, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, IranCorrespondence: Hadi BazyarNutrition and Metabolic Diseases Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, IranTel +98 9136659629Email hadibazyar2015@gmail.comBackground and Aim: The imbalance between pro-oxidant and antioxidant systems often leads to further oxidative damage in the pathogenesis of both diabetes and periodontal disease. This study aimed to investigate the antioxidant and anti-inflammatory properties of melatonin in type 2 diabetes mellitus (T2DM) patients with periodontal disease (PD) under non-surgical periodontal therapy (NSPT).Materials and Methods: In this double-blind clinical trial study, 50 T2DM patients with PD were randomly allocated to intervention and control groups and received 250 mg/day (2 tablets) either melatonin or placebo 1 h before bedtime for 8 weeks. The NSPT was performed for all patients in both groups at the beginning of the study. The serum levels of interleukin-1b (IL-1b), malondialdehyde (MDA), total antioxidant capacity (TAC), superoxide dismutase (SOD), catalase (CAT), and glutathione peroxidase (GPx) were measured pre- and post-intervention.Results: Supplementation with melatonin in adjunct to NSPT significantly increased the serum levels of TAC, SOD, CAT, and GPx in the intervention group (P = 0.02, 0.008, 0.004 and 0.004, respectively). The mean changes of SOD, CAT, and GPx were significantly (P = 0.02, 0.04 and 0.04, respectively) greater in the intervention group compared with the control group. Also, after adjusting for confounding factors, the results did not change in terms of significance (P < 0.05). After the intervention, serum levels of MDA and IL-1b were significantly reduced in the intervention group (P < 0.001 and P = 0.008, respectively). The intervention group exhibited lower mean changes of MDA compared with the control group, and these changes were statistically significant (P = 0.008). In addition, after adjusting for confounding factors, the results did not change in terms of significance.Conclusion: The adjunctive effects of melatonin and NSPT may improve inflammatory and antioxidant parameters in T2DM patients with PD.Keywords: type 2 diabetes mellitus, periodontal disease, melatonin, inflammatory markers, antioxidant enzymeshttps://www.dovepress.com/antioxidant-and-anti-inflammatory-properties-of-melatonin-in-patients--peer-reviewed-article-DMSOtype 2 diabetes mellitusperiodontal diseasemelatonininflammatory markersantioxidant enzymes |
spellingShingle | Zare Javid A Hosseini SA Gholinezhad H Moradi L Haghighi-zadeh MH Bazyar H Antioxidant and Anti-Inflammatory Properties of Melatonin in Patients with Type 2 Diabetes Mellitus with Periodontal Disease Under Non-Surgical Periodontal Therapy: A Double-Blind, Placebo-Controlled Trial Diabetes, Metabolic Syndrome and Obesity type 2 diabetes mellitus periodontal disease melatonin inflammatory markers antioxidant enzymes |
title | Antioxidant and Anti-Inflammatory Properties of Melatonin in Patients with Type 2 Diabetes Mellitus with Periodontal Disease Under Non-Surgical Periodontal Therapy: A Double-Blind, Placebo-Controlled Trial |
title_full | Antioxidant and Anti-Inflammatory Properties of Melatonin in Patients with Type 2 Diabetes Mellitus with Periodontal Disease Under Non-Surgical Periodontal Therapy: A Double-Blind, Placebo-Controlled Trial |
title_fullStr | Antioxidant and Anti-Inflammatory Properties of Melatonin in Patients with Type 2 Diabetes Mellitus with Periodontal Disease Under Non-Surgical Periodontal Therapy: A Double-Blind, Placebo-Controlled Trial |
title_full_unstemmed | Antioxidant and Anti-Inflammatory Properties of Melatonin in Patients with Type 2 Diabetes Mellitus with Periodontal Disease Under Non-Surgical Periodontal Therapy: A Double-Blind, Placebo-Controlled Trial |
title_short | Antioxidant and Anti-Inflammatory Properties of Melatonin in Patients with Type 2 Diabetes Mellitus with Periodontal Disease Under Non-Surgical Periodontal Therapy: A Double-Blind, Placebo-Controlled Trial |
title_sort | antioxidant and anti inflammatory properties of melatonin in patients with type 2 diabetes mellitus with periodontal disease under non surgical periodontal therapy a double blind placebo controlled trial |
topic | type 2 diabetes mellitus periodontal disease melatonin inflammatory markers antioxidant enzymes |
url | https://www.dovepress.com/antioxidant-and-anti-inflammatory-properties-of-melatonin-in-patients--peer-reviewed-article-DMSO |
work_keys_str_mv | AT zarejavida antioxidantandantiinflammatorypropertiesofmelatonininpatientswithtype2diabetesmellituswithperiodontaldiseaseundernonsurgicalperiodontaltherapyadoubleblindplacebocontrolledtrial AT hosseinisa antioxidantandantiinflammatorypropertiesofmelatonininpatientswithtype2diabetesmellituswithperiodontaldiseaseundernonsurgicalperiodontaltherapyadoubleblindplacebocontrolledtrial AT gholinezhadh antioxidantandantiinflammatorypropertiesofmelatonininpatientswithtype2diabetesmellituswithperiodontaldiseaseundernonsurgicalperiodontaltherapyadoubleblindplacebocontrolledtrial AT moradil antioxidantandantiinflammatorypropertiesofmelatonininpatientswithtype2diabetesmellituswithperiodontaldiseaseundernonsurgicalperiodontaltherapyadoubleblindplacebocontrolledtrial AT haghighizadehmh antioxidantandantiinflammatorypropertiesofmelatonininpatientswithtype2diabetesmellituswithperiodontaldiseaseundernonsurgicalperiodontaltherapyadoubleblindplacebocontrolledtrial AT bazyarh antioxidantandantiinflammatorypropertiesofmelatonininpatientswithtype2diabetesmellituswithperiodontaldiseaseundernonsurgicalperiodontaltherapyadoubleblindplacebocontrolledtrial |